SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
SmartTRAK interviews Oxford Performance Materials CEO Scott DeFelice to learn more about the company’s P...
SmartTRAK reports that Q322 Spine Market performance drove a lack of consensus on operational performanc...
Despite declining OUS results, the US Trauma Market experienced healthy growth attributed to adoption of...
Q322 sees a tidal wave of new robotic spine surgery competitors as well as data-driven initiatives under...
SmartTRAK interviews Bolt Navigation CEO Patrick West to learn more about the Company and its potentiall...
In the market for Trauma & Extremities, companies continue to innovate with new product introduction...
Highlighting the economic conversation at AAHKS 2022 changing the landscape of joint replacement At the ...
For the first time in recent years, robotics was not a main headline in the academic program at NASS 202...
SmartTRAK highlights new products and Company strategies to penetrate the Foot & Ankle space at AOFA...
SmartTRAK identified several trends at NASS 2022 that have the potential to improve patient care and dri...
Login